# OrigoBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/origobio

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Website: www.origobio.com
- Total disclosed funding: $14M
- Latest round: Series A (Jul 22, 2026)
- Investors on record: 6

## About

Based in Hangzhou, China and founded in 2022,  Hangzhou OrigO Biotechnology Co., Ltd., dba OrigoBio, has established a research and development platform called NCVx, built on intelligent nanovesicle technology. The company’s core scientific achievements have been published in leading international journals such as Nature, Matter, and JACS, and its innovations have progressed toward clinical application. In July 2026, OrigoBio closed Series A+ funding from Puhua Capital, Ningbo Danbei Investment Management Partnership, HangZhou Capital, Zhejiang University Holding, and other investors.

OrigoBio develops therapeutic solutions leveraging nanovesicle technology for tissue repair and regenerative medicine. The company's NCVx platform integrates intelligent nanovesicle engineering to enable novel treatment approaches, targeting applications across healthcare and clinical practice.

The company is expected to generate revenue from the development, licensing, and commercialization of nanovesicle-based therapies, as well as from research collaborations in regenerative medicine.

## Funding rounds

- Series A, Jul 22, 2026 — Puhua Capital, HangZhou Capital, Ningbo Danbei Investment Management Partnership, Zhejiang University Holding
- Series A, Sep 11, 2025, $14M — Lotus Lake Capital, Zheshang Venture Capital

## Investors

- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series A
- Zheshang Venture Capital (https://capitalatlas.ai/funds/zheshang-venture-capital) — Series A
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Series A
- HangZhou Capital (https://capitalatlas.ai/funds/hangzhou-capital) — Series A
- Ningbo Danbei Investment Management Partnership (https://capitalatlas.ai/funds/ningbo-danbei-investment-management-partnership) — Series A
- Zhejiang University Holding (https://capitalatlas.ai/funds/zhejiang-university-holding) — Series A